Literature DB >> 2006762

Pheochromocytoma with electrocardiographic change mimicking angina pectoris, and cyclic change in direct arterial pressure--a case report.

K Murai1, K Hirota, T Niskikimi, T Kawarabayashi, M Yoshiyama, M Yasuda, M Teragaki, K Akioka, H Oku, K Takeuchi.   

Abstract

A forty-two-year-old man was admitted because of chest pain. Electrocardiograms at admission showed horizontal ST depression in leads, II, III, aVF, V4, V5, and V6. Direct blood pressure monitoring revealed cyclic change between 160/100 mmHg and 70/50 mmHg and heart rate between 80/sec and 120/sec at fifteen minute intervals. The plasma norepinephrine and epinephrine concentrations were elevated during the episodes of hypertension. Pheochromocytoma was found in the right adrenal gland. These cyclic changes in blood pressure and heart rate are an aid for diagnosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2006762     DOI: 10.1177/000331979104200212

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  4 in total

Review 1.  Pheochromocytoma as an endocrine emergency.

Authors:  Frederieke M Brouwers; Jacques W M Lenders; Graeme Eisenhofer; Karel Pacak
Journal:  Rev Endocr Metab Disord       Date:  2003-05       Impact factor: 6.514

Review 2.  Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction.

Authors:  Ivana Jochmanová; Chunzhang Yang; Zhengping Zhuang; Karel Pacak
Journal:  J Natl Cancer Inst       Date:  2013-08-12       Impact factor: 13.506

3.  Extreme and Cyclical Blood Pressure Elevation in a Pheochromocytoma Hypertensive Crisis.

Authors:  V Larouche; N Garfield; E Mitmaker
Journal:  Case Rep Endocrinol       Date:  2018-07-15

4.  Clinical features, complications, and outcomes of exogenous and endogenous catecholamine-triggered Takotsubo syndrome: A systematic review and meta-analysis of 156 published cases.

Authors:  Shams Y-Hassan; Henrik Falhammar
Journal:  Clin Cardiol       Date:  2020-03-03       Impact factor: 2.882

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.